Cited by 320Substance Abuse Treatment and OutcomesOpioid Use Disorder TreatmentSmoking Behavior and Cessation

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients

Open access

McNeely, Jennifer, Wu, Li-Tzy, Subramaniam, Geetha, Sharma, Gaurav, Cathers, Lauretta A., Svikis, Dace, Sleiter, Luke, Russell, Linnea, Nordeck, Courtney, Sharma, Anjalee, O'Grady, Kevin E., Bouk, Leah B., Cushing, Carol, King, Jacqueline, Wahle, Aimee, Schwartz, Robert P.·2016·Annals of Internal Medicine

DOI 10.7326/m16-0317PMC PMC5291717

Open this paper in CoChat — free account

Abstract

BACKGROUND: Substance use, a leading cause of illness and death, is underidentified in medical practice. OBJECTIVE: The Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) tool was developed to address the need for a brief screening and assessment instrument that includes all commonly used substances and fits into clinical workflows. The goal of this study was to assess the performance of the TAPS tool in primary care patients. DESIGN: Multisite study, conducted within the National Drug Abuse Treatment Clinical Trials Network, comparing the TAPS tool with a reference standard measure. (ClinicalTrials.gov: NCT02110693). SETTING: 5 adult primary care clinics. PARTICIPANTS: 2000 adult patients consecutively recruited from clinic waiting areas. MEASUREMENTS: Interviewer- and self-administered versions of the TAPS tool were compared with a reference standard, the modified World Mental Health Composite International Diagnostic Interview (CIDI), which measures problem use and substance use disorder (SUD). RESULTS: Interviewer- and self-administered versions of the TAPS tool had similar diagnostic characteristics. For identifying problem use (at a cutoff of 1+), the TAPS tool had a sensitivity of 0.93 (95% CI, 0.90 to 0.95) and specificity of 0.87 (CI, 0.85 to 0.89) for tobacco and a sensitivity of 0.74 (CI, 0.70 to 0.78) and specificity of 0.79 (CI, 0.76 to 0.81) for alcohol. For problem use of illicit and prescription drugs, sensitivity ranged from 0.82 (CI, 0.76 to 0.87) for marijuana to 0.63 (CI, 0.47 to 0.78) for sedatives; specificity was 0.93 or higher. For identifying any SUD (at a cutoff of 2+), sensitivity was lower. LIMITATIONS: The low prevalence of some drug classes led to poor precision in some estimates. Research assistants were not blinded to participants' TAPS tool responses when they administered the CIDI. CONCLUSION: In a diverse population of adult primary care patients, the TAPS tool detected clinically relevant problem substance use. Although it also may detect tobacco, alcohol, and marijuana use disorders, further refinement is needed before it can be recommended broadly for SUD screening. PRIMARY FUNDING SOURCE: National Institute on Drug Abuse.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.7326/m16-0317

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,781
Actual Causes of Death in the United States, 2000
Mokdad, A. H. (2004) · JAMA · doi:10.1001/jama.291.10.1238 · Cited by 5,211
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990
The drug abuse screening test
Skinner, H. A. (1982) · Addictive Behaviors · doi:10.1016/0306-4603(82)90005-3 · Cited by 3,134 · cited 1×
“Neither the widely used Drug Abuse Screening Test (25, 51) nor the newer Screen of Drug Use (29) provides this level of detail.”
Background
The Composite International Diagnostic Interview: An Epidemiologic Instrument Suitable for Use in Conjunction With Different Diagnostic Systems and in Different Cultures
Robins, L. N. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360017003 · Cited by 2,909
The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors
Danaei, G., Ding, E. L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C. J. L., & Ezzati, M. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000058 · Cited by 2,860
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
Causland, F. R. M., Brunelli, S. M., & Waikar, S. S. (2013) · American Journal of Nephrology · doi:10.1159/000355958 · Cited by 2,705
The Statistical Evaluation of Medical Tests for Classification and Prediction
PEPE, M. S. (2005) · Technometrics · doi:10.1198/tech.2005.s278 · Cited by 1,907
AUDIT‐C as a Brief Screen for Alcohol Misuse in Primary Care
Bradley, K. A., Rubinsky, A. D., Volk, R. J., Williams, E. C., Frank, D., & Kivlahan, D. R. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00403.x · Cited by 1,634

Flagged first, then by citations

Show all 68 references

Research works printed but not linked: 8

Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, 61, 10
10.1007/s11606-002-0044-3 · DOI
Centers for Disease Control and Prevention (CDC), 2007, MMWR Morb Mortal Wkly Rep, 56, 93
Centers for Medicare & Medicaid Services (CMS), HHS, 2012, Final rule. Fed Regist, 77, 53967
Wight RG, 2000, AIDS Educ Prev, 12, 431
Babor TF, 1990, Behav Assess, 12, 5
Hser YI, 1997, NIDA Res Monogr, 167, 320
Merrill JO, 2002, J Gen Intern Med, 17, 327

Sorted by citations

CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7103a1 · Cited by 1,886
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Volkow, N. D., & Blanco, C. (2023) · World psychiatry · doi:10.1002/wps.21073 · Cited by 503
Management of opioid use disorder in the USA: present status and future directions
Blanco, C., & Volkow, N. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33078-2 · Cited by 407
Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
O’Connor, E. A., Perdue, L. A., Senger, C. A., Rushkin, M., Patnode, C. D., Bean, S. I., & Jonas, D. E. (2018) · JAMA · doi:10.1001/jama.2018.12086 · Cited by 249
Screening for Behavioral Health Conditions in Primary Care Settings: A Systematic Review of the Literature
Mulvaney‐Day, N., Marshall, T., Piscopo, K. D., Korsen, N., Lynch, S. E., Karnell, L. H., Moran, G. E., Daniels, A. S., & Ghose, S. S. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4181-0 · Cited by 201
The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management
McIntyre, R. S., Alda, M., Baldessarini, R. J., Bauer, M., Berk, M., Correll, C. U., Fagiolini, A., Fountoulakis, K., Frye, M. A., Grunze, H., et al. (2022) · World Psychiatry · doi:10.1002/wps.20997 · Cited by 171
Chronic Pancreatitis
Vege, S. S., & Chari, S. T. (2022) · New England Journal of Medicine · doi:10.1056/nejmcp1809396 · Cited by 158
The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study
Winhusen, T. M., Walley, A. Y., Fanucchi, L. C., Hunt, T., Lyons, M., Lofwall, M. R., Brown, J. L., Freeman, P. R., Nunes, E. V., Beers, D., et al. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108325 · Cited by 135
Management of Infective Endocarditis in People Who Inject Drugs: A Scientific Statement From the American Heart Association
Baddour, L. M., Weimer, M. B., Wurcel, A. G., McElhinney, D. B., Marks, L. R., Fanucchi, L. C., Garrigos, Z. E., Pettersson, G., & DeSimone, D. C. (2022) · Circulation · doi:10.1161/cir.0000000000001090 · Cited by 137
Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients
John, W. S., Zhu, H., Mannelli, P., Schwartz, R. P., Subramaniam, G., & Wu, L.-T. T. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.01.035 · Cited by 132
Self-citation
The disparate impact of COVID-19 on the mental health of female and male caregivers
Wade, M., Prime, H., Johnson, D., May, S. S., Jenkins, J. M., & Browne, D. T. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.113801 · Cited by 131
Prevalence and treatment of opioid use disorders among primary care patients in six health systems
Lapham, G. T., Boudreau, D. M., Johnson, E. A., Bobb, J. F., Matthews, A. G., McCormack, J., Liu, D., Samet, J. H., Saxon, A. J., Campbell, C. I., et al. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107732 · Cited by 106
Self-citation
Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care
Gryczynski, J., McNeely, J., Wu, L.-T. T., Subramaniam, G., Svikis, D. S., Cathers, L. A., Sharma, G., King, J., Jelstrom, E., Nordeck, C. D., et al. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4079-x · Cited by 86
Self-citation
The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network
Marsch, L. A., Campbell, A. N. C., Campbell, C. I., Chen-Ritzo, C.-H., Ertin, E., Ghitza, U. E., Lambert-Harris, C. A., Hassanpour, S., Holtyn, A. F., Hser, Y., et al. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.02.005 · Cited by 88
Self-citation
Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Patnode, C. D., Perdue, L. A., Rushkin, M., Dana, T., Blazina, I., Bougatsos, C., Grusing, S., O’Connor, E. A., Fu, R., & Chou, R. (2020) · JAMA · doi:10.1001/jama.2019.21381 · Cited by 73
Alcohol‐related head and neck cancer: Summary of the literature
Marziliano, A. M., Teckie, S., & Diefenbach, M. A. (2019) · Head & Neck · doi:10.1002/hed.26023 · Cited by 74
Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics
McNeely, J., Adam, A., Rotrosen, J., Wakeman, S. E., Wilens, T. E., Kannry, J. L., Rosenthal, R. N., Wahle, A., Pitts, S., Farkas, S., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.10721 · Cited by 72
Self-citation
Routine Assessment of Symptoms of Substance Use Disorders in Primary Care: Prevalence and Severity of Reported Symptoms
Sayre, M., Lapham, G. T., Lee, A. K., Oliver, M. M., Bobb, J. F., Caldeiro, R. M., & Bradley, K. A. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-05650-3 · Cited by 68
Trends and correlates of cocaine use among adults in the United States, 2006–2019
Mustaquim, D., Jones, C. M., & Compton, W. M. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.106950 · Cited by 68
Integrating Treatment for Co-Occurring Mental Health Conditions
Yule, A. (2019) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v40.1.07 · Cited by 63
A Quality Framework for Emergency Department Treatment of Opioid Use Disorder
Samuels, E. A., D’Onofrio, G., Huntley, K., Levin, S., Schuur, J. D., Bart, G. B., Hawk, K. F., Tai, B., Campbell, C. I., & Venkatesh, A. K. (2018) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2018.08.439 · Cited by 64
Prevalence of documented alcohol and opioid use disorder diagnoses and treatments in a regional primary care practice-based research network
Hallgren, K. A., Witwer, E., West, I. I., Baldwin, L., Donovan, D. M., Stuvek, B., Keppel, G. A., Mollis, B. L., & Stephens, K. A. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.11.008 · Cited by 60
Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems
Boudreau, D. M., Lapham, G. T., Johnson, E. A., Bobb, J. F., Matthews, A. G., McCormack, J., Liu, D. S., Campbell, C. I., Rossom, R. C., Binswanger, I. A., et al. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.02.001 · Cited by 61
Self-citation
Developing an Adaptive Mobile Intervention to Address Risky Substance Use Among Adolescents and Emerging Adults: Usability Study
Coughlin, L. N., Nahum-Shani, I. B., Philyaw-Kotov, M. L., Bonar, E. E., Rabbi, M., Klasnja, P., Murphy, S. A., & Walton, M. A. (2021) · JMIR mhealth and uhealth · doi:10.2196/24424 · Cited by 62
Screening for Substance Use in Rural Primary Care: a Qualitative Study of Providers and Patients
Saunders, E. C., Moore, S. K., Gardner, T., Farkas, S., Marsch, L. A., McLeman, B. M., Meier, A., Nesin, N., Rotrosen, J., Walsh, O., et al. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05232-y · Cited by 58
Self-citation
Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine
Calcaterra, S. L., Martín, M., Bottner, R., Englander, H. L., Weinstein, Z., Weimer, M. B., Lambert, E., & Herzig, S. J. (2022) · Journal of Hospital Medicine · doi:10.1002/jhm.12893 · Cited by 58
DSM-5 substance use disorders among adult primary care patients: Results from a multisite study
Wu, L.-T. T., McNeely, J., Subramaniam, G., Brady, K. T., Sharma, G., VanVeldhuisen, P., Zhu, H., & Schwartz, R. P. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.05.048 · Cited by 54
Self-citation
Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders
Saunders, E. C., Moore, S. K., Walsh, O., Metcalf, S. A., Budney, A. J., Scherer, E. A., & Marsch, L. A. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.01.009 · Cited by 51
Identification and Management of Opioid Use Disorder in Primary Care: an Update
Donroe, J. H., Bhatraju, E. P., Tsui, J. I., & Edelman, E. J. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01149-0 · Cited by 46
Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool
Adam, A., Schwartz, R. P., Wu, L.-T. T., Subramaniam, G., LASKA, E. M., Sharma, G., Mili, S., & McNeely, J. (2019) · Addiction Science & Clinical Practice · doi:10.1186/s13722-019-0167-z · Cited by 44
Self-citation
Validity of the Single-Item Screen–Cannabis (SIS-C) for Cannabis Use Disorder Screening in Routine Care
Matson, T. E., Lapham, G. T., Bobb, J. F., Oliver, M. M., Hallgren, K. A., Williams, E. C., & Bradley, K. A. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.39772 · Cited by 44
Validation of the NIDA-modified ASSIST as a Screening Tool for Prenatal Drug Use in an Urban Setting in the United States
Oga, E. A., Mark, K., Peters, E. N., & Coleman‐Cowger, V. H. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000614 · Cited by 46
Preventive care recommendations to promote health equity
Persaud, N., Sabir, A., Woods, H., Sayani, A., Agarwal, A., Chowdhury, M., de Leon-Demare, K., Ibezi, S., Jan, S. H., Katz, A., et al. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.230237 · Cited by 46
Home-based virtual reality for chronic pain: protocol for an NIH-supported randomised-controlled trial
Birckhead, B. J., Eberlein, S. A., Alvarez, G., Gale, R., Dupuy, T. P., Makaroff, K. E., Fuller, G., Liu, X., Yu, K., Black, J. T., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050545 · Cited by 37
Childhood trauma and schizotypy in non-clinical samples: A systematic review and meta-analysis
Toutountzidis, D., Gale, T. M., Irvine, K., Sharma, S., & Laws, K. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270494 · Cited by 37
Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco
John, W. S., Zhu, H., Mannelli, P., Subramaniam, G., Schwartz, R. P., McNeely, J., & Wu, L.-T. T. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.11.011 · Cited by 35
Self-citation
Addressing Unhealthy Substance Use in Primary Care
Pace, C. A., & Uebelacker, L. A. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.02.004 · Cited by 35
Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial
Hser, Y., Ober, A. J., Dopp, A. R., Lin, C., Osterhage, K. P., Clingan, S. E., Mooney, L. J., Curtis, M. E., Marsch, L. A., McLeman, B. M., et al. (2021) · Addiction Science & Clinical Practice · doi:10.1186/s13722-021-00233-x · Cited by 35
Addressing identification bias in the design and analysis of cluster-randomized pragmatic trials: a case study
Bobb, J. F., Qiu, H., Matthews, A. G., McCormack, J., & Bradley, K. A. (2020) · Trials · doi:10.1186/s13063-020-4148-z · Cited by 31
Evidence-Based Assessment of Substance Use Disorder
Boness, C. L., González, J. C., Sleep, C. E., Venner, K. L., & Witkiewitz, K. A. (2023) · Assessment · doi:10.1177/10731911231177252 · Cited by 30
Validation and threshold identification of a prescription drug monitoring program clinical opioid risk metric with the WHO alcohol, smoking, and substance involvement screening test
Cochran, G., Brown, J. L., Yu, Z., Frede, S. M., Bryan, M. A., Ferguson, A. M., Bayyari, N., Taylor, B., Snyder, M. E., Charron, E. M., et al. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109067 · Cited by 28
Psychometric Performance of a Substance Use Symptom Checklist to Help Clinicians Assess Substance Use Disorder in Primary Care
Matson, T. E., Hallgren, K. A., Lapham, G. T., Oliver, M. M., Wang, X., Williams, E., & Bradley, K. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.16283 · Cited by 24
Workshop on Implementation Science and Digital Therapeutics for Behavioral Health
Lord, S., Campbell, A. N. C., Brunette, M. F., Cubillos, L., Bartels, S. M., Torrey, W. C., Olson, A. L., Chapman, S. H., Batsis, J. A., Polsky, D. E., et al. (2020) · JMIR Mental Health · doi:10.2196/17662 · Cited by 29
Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST
Schwartz, R. P., McNeely, J., Wu, L.-T. T., Sharma, G., Wahle, A., Cushing, C., Nordeck, C. D., Sharma, A., O’Grady, K. E., Gryczynski, J., et al. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.01.013 · Cited by 26
Self-citation
Clinical implementation of AI-based screening for risk for opioid use disorder in hospitalized adults
Afshar, M., Resnik, F., Joyce, C., Oguss, M. K., Dligach, D., Burnside, E. S., Sullivan, A. G., Churpek, M. M., Patterson, B. W., Salisbury‐Afshar, E., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03603-z · Cited by 27
Latent Classes of Adverse and Benevolent Childhood Experiences in a Multinational Sample of Parents and Their Relation to Parent, Child, and Family Functioning during the COVID-19 Pandemic
Johnson, D., Browne, D. T., Meade, R. D., Prime, H., & Wade, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192013581 · Cited by 25
Readiness to Provide Medications for Addiction Treatment in HIV Clinics: A Multisite Mixed-Methods Formative Evaluation
Edelman, E. J., Gan, G., Dziura, J. D., Esserman, D. A., Morford, K. L., Porter, E., Chan, P. A., Cornman, D. H., Oldfield, B. J., Yager, J. E., et al. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002666 · Cited by 25
The design and methods of the OPTIMUM study: A multisite pragmatic randomized clinical trial of a telehealth group mindfulness program for persons with chronic low back pain
Greco, C. M., Gaylord, S. A., Faurot, K. R., Weinberg, J., Gardiner, P. M., Roth, I., Barnhill, J. L., Thomas, H. N., Dhamne, S. C., Lathren, C., et al. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106545 · Cited by 25
Prevalence of Unhealthy Substance Use and Associated Characteristics Among Patients Presenting for Surgery
Fernandez, A. C., Waljee, J. F., Gunaseelan, V., Brummett, C. M., Englesbe, M. J., & Bicket, M. C. (2022) · Annals of Surgery · doi:10.1097/sla.0000000000005767 · Cited by 24
A randomized controlled trial of social media interventions for risky drinking among adolescents and emerging adults
Bonar, E. E., Bauermeister, J. A., Blow, F. C., Bohnert, A. S. B., Bourque, C., Coughlin, L. N., Davis, A. K., Florimbio, A. R., Goldstick, J. E., Wisnieski, D. M., et al. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109532 · Cited by 23
Multi-Site Observational Study to Assess Biomarkers for Susceptibility or Resilience to Chronic Pain: The Acute to Chronic Pain Signatures (A2CPS) Study Protocol
Berardi, G., Frey‐Law, L., Sluka, K. A., Bayman, E. O., Coffey, C. S., Ecklund, D. J., Vance, C. G. T., Dailey, D. L., Burns, J. W., Buvanendran, A., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.849214 · Cited by 25
Acute Mental Health Symptoms in Adolescent Marijuana Users
Levy, S., & Weitzman, E. R. (2018) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2018.3811 · Cited by 21
Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review
Lindley, B., Cox, N., & Cochran, G. (2019) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s185663 · Cited by 21
Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report
Bart, G. B., Saxon, A. J., Fiellin, D. A., McNeely, J., Muench, J., Shanahan, C. W., Huntley, K., & Gore‐Langton, R. E. (2020) · Addiction Science & Clinical Practice · doi:10.1186/s13722-020-0180-2 · Cited by 22
Self-citation
“It’s way more than just writing a prescription”: A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder
Saunders, E. C., Moore, S. K., Walsh, O., Metcalf, S. A., Budney, A. J., Cavazos‐Rehg, P. A., Scherer, E. A., & Marsch, L. A. (2021) · Addiction Science & Clinical Practice · doi:10.1186/s13722-021-00213-1 · Cited by 21
Validation of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool with the WHO alcohol, smoking, and substance Involvement screening test (ASSIST)
Carter, G. C., Yu, Z., Bryan, M. A., Brown, J. L., Winhusen, T. M., & Cochran, G. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107178 · Cited by 20
Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial
Satre, D. D., Anderson, A. N., Leibowitz, A., Levine‐Hall, T., Slome, S. B., Flamm, J., Hare, C. B., McNeely, J., Weisner, C. M., Horberg, M. A., et al. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.105833 · Cited by 20
Self-citation
Caring about caregivers: the role of paediatricians in supporting the mental health of parents of children with high caregiving needs
Rotberg, B., Wittenberg, J., Orkin, J., Saunders, N. R., & Cohen, E. (2020) · Archives of Disease in Childhood · doi:10.1136/archdischild-2019-318729 · Cited by 20
Exposure and Risk Factors for COVID-19 and the Impact of Staying Home on 8,047 Biorepository Participants
Wu, K.-H., Hornsby, W., Klunder, B., Krause, A., Driscoll, A., Kulka, J., Bickett-Hickok, R., Fellows, A., Graham, S. E., Kaleba, E. O., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0246447 · Cited by 22
Dysfunctional parenting and emotional problems and substance misuse: Enhancing psychological flexibility in college students
Arslan, G. (2023) · Journal of Ethnicity in Substance Abuse · doi:10.1080/15332640.2023.2237930 · Cited by 25
Identifying available addictive disorder screening tests validated in primary care: A systematic review
Pautrat, M., Lebeau, J., & Laporte, C. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107180 · Cited by 19
Non-pharmacological Options in Postoperative Hospital-Based and Rehabilitation Pain Management (NOHARM): Protocol for a Stepped-Wedge Cluster-Randomized Pragmatic Clinical Trial
Redmond, S. A., Tilburt, J. C., & Cheville, A. L. (2022) · Pain and Therapy · doi:10.1007/s40122-022-00393-x · Cited by 21
Addiction Medicine Practice-Based Research Network (AMNet): Assessment Tools and Quality Measures
Clarke, D. E., Ibrahim, A., Doty, B., Patel, S., Gibson, D., Pagano, A., Thompson, L. R., Goldstein, A. B., Vocci, F. J., & Schwartz, R. P. (2021) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s305972 · Cited by 18
Self-citation
Opioid Use Disorder Diagnosis and Management
Wakeman, S. E. (2022) · NEJM Evidence · doi:10.1056/evidra2200038 · Cited by 17
Considerations for Treating Young People With Comorbid Autism Spectrum Disorder and Substance Use Disorder
Isenberg, B. M., Yule, A. M., McKowen, J. W., Nowinski, L. A., Forchelli, G. A., & Wilens, T. E. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.08.467 · Cited by 17
Cannabis use, other drug use, and risk of subsequent acute care in primary care patients
Matson, T. E., Lapham, G. T., Bobb, J. F., Johnson, E., Richards, J. A., Lee, A. K., Bradley, K. A., & Glass, J. E. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108227 · Cited by 17
Substance Use Disorders in Women
Polak, K., Haug, N. A., Dillon, P. M., & Svikis, D. S. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.04.006 · Cited by 17
Self-citation
Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients
McNeely, J., McLeman, B. M., Gardner, T., Nesin, N., Amarendran, V., Farkas, S., Wahle, A., Pitts, S., Kline, M., King, J., et al. (2023) · Addiction Science & Clinical Practice · doi:10.1186/s13722-023-00404-y · Cited by 16
Self-citation
Technological Innovations in Addiction Treatment
Budney, A. J., Borodovsky, J. T., Marsch, L. A., & Lord, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54856-4.00005-5 · Cited by 17
Management of alcohol withdrawal syndromes in general hospital settings
Kast, K. A., Sidelnik, S. A., Nejad, S. H., & Suzuki, J. (2025) · BMJ · doi:10.1136/bmj-2024-080461 · Cited by 18
Racial Equity in Urine Drug Screening Policies in Labor and Delivery
Azimi, V., Trammel, C. J., Nacke, L., Rubin, A., Stevenson, L., Vaughn, B., Roper, S. M., Zaydman, M. A., Jackups, R., Riaz, N., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.0908 · Cited by 15
Clinical Decision Support System for Primary Care of Opioid Use Disorder
Rossom, R. C., Crain, A. L., Wright, E. A., Olson, A. W., Haller, I. V., Haapala, J. L., Dehmer, S. P., Hooker, S. A., Solberg, L. I., O’Connor, P. J., et al. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.2535 · Cited by 15
Hybrid effectiveness-implementation trial of guided relaxation and acupuncture for chronic sickle cell disease pain (GRACE): A protocol
Doorenbos, A. Z., Schlaeger, J. M., deMartelly, V. A., Burke, L., Boyd, A. D., Knisely, M. R., Leigh, J. W., Li, H., Mandernach, M. W., Molokie, R. E., et al. (2023) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2023.101076 · Cited by 15
A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder
Rossom, R. C., Sperl‐Hillen, J. M., O’Connor, P. J., Crain, A. L., Nightingale, L., Pylkas, A. M., Huntley, K., & Bart, G. B. (2021) · Addiction Science & Clinical Practice · doi:10.1186/s13722-021-00245-7 · Cited by 15
Screening for Unhealthy Alcohol and Drug Use in General Medicine Settings
McNeely, J., & Hamilton, L. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.08.002 · Cited by 14
Self-citation
Three-arm randomised controlled trial of an m-health app and digital engagement strategy for improving treatment adherence and reducing suicidal ideation in young people: study protocol
McGillivray, L., Gan, D. Z. Q., Wong, Q. J. J., Han, J., Hetrick, S. E., Christensen, H. M., & Torok, M. H. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058584 · Cited by 16
Prescription drug misuse in adolescents and young adults
Siste, K., Nugraheni, P., Christian, H., Suryani, E., & Firdaus, K. K. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000520 · Cited by 14
A digital tool to promote alcohol and drug use screening, brief intervention, and referral to treatment skill translation: A mobile app development and randomized controlled trial protocol
Satre, D. D., Ly, K., Wamsley, M., Curtis, A., & Satterfield, J. (2017) · JMIR Research Protocols · doi:10.2196/resprot.7070 · Cited by 13
Biobehavioral Assessments in BACPAC: Recommendations, Rationale, and Methods
Greco, C. M., Wasan, A. D., Schneider, M. J., Mehling, W., Williams, D. A., Darwin, J., & Harte, S. E. (2023) · Pain Medicine · doi:10.1093/pm/pnac175 · Cited by 13
Early implementation of screening for substance use in rural primary care: A rapid analytic qualitative study
Moore, S. K., Saunders, E. C., Hichborn, E. G., McLeman, B. M., Meier, A., Young, R., Nesin, N., Farkas, S., Hamilton, L., Marsch, L. A., et al. (2020) · Substance Abuse · doi:10.1080/08897077.2020.1827125 · Cited by 13
Self-citation
Young Adult Healthcare Exposure and Future Opioid Misuse: A Prospective Cohort Study
Fergus, K. B., Schwab, M. E., Butler, C., Cattle, C. J., Breyer, B. N., Copp, H. L., & Nagata, J. M. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.12.026 · Cited by 13
Evidence and best practices for trauma-informed care in gynecologic oncology patients
Fulton, J., Snyder, H., Chalif, J., Delwiche, K., & Chambers, L. (2024) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2024-005300 · Cited by 14
A Brief Screening Tool for Opioid Use Disorder: EMPOWER Study Expert Consensus Protocol
You, D. S., Mardian, A. S., Darnall, B. D., Chen, C. A., Bruyne, K. D., Flood, P. D., Kao, M. J., Karnik, A. D., McNeely, J., Porter, J., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.591201 · Cited by 13
Self-citation
Patient and provider perspectives on self-administered electronic substance use and mental health screening in HIV primary care
Lea, A. N., Altschuler, A., Leibowitz, A., Levine‐Hall, T., McNeely, J., Silverberg, M. J., & Satre, D. D. (2022) · Addiction Science & Clinical Practice · doi:10.1186/s13722-022-00293-7 · Cited by 13
Self-citation
Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care
Rossom, R. C., Crain, A. L., O’Connor, P. J., Wright, E. A., Haller, I. V., Hooker, S. A., Sperl‐Hillen, J. M., Olson, A. W., Romagnoli, K. M., Solberg, L. I., et al. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.107012 · Cited by 13
Pilot Studies Examining Feasibility of Substance Use Disorder Screening and Treatment Linkage at Urban Sexually Transmitted Disease Clinics
Gryczynski, J., Nordeck, C. D., Mitchell, S. G., Page, K. R., Johnsen, L. E., O’Grady, K. E., & Schwartz, R. P. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000327 · Cited by 13
Self-citation
Ontological insecurity I: Psychometric development of a new measure and relationship to subclinical psychotic‐like experiences
Marlowe, N. I., Perry, K. N., & Lee, J. (2019) · Journal of Clinical Psychology · doi:10.1002/jclp.22849 · Cited by 14
Comparison of timeline follow-back self-report and oral fluid testing to detect substance use in adult primary care patients
Nordeck, C. D., Gryczynski, J., O’Grady, K. E., Polak, K., Svikis, D. S., McNeely, J., Wu, L.-T. T., & Schwartz, R. P. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107939 · Cited by 12
Self-citation
How much or how often? Examining the screening properties of the DSM cross-cutting symptom measure in a youth population-based sample
Pacheco, J. P. G., Kieling, C., Manfro, P. H., Menezes, A. M. B., Gonçalves, H., Oliveira, I. O., Wehrmeister, F. C., Rohde, L. A., & Hoffmann, M. S. (2024) · Psychological Medicine · doi:10.1017/s0033291724000849 · Cited by 12
Development and Psychometric Evaluation of the Lifestyle Medicine Health Behavior Scale
Pangalangan, J. M. L., Puma, J. E., Tollefson, M., & Frates, B. (2024) · American Journal of Lifestyle Medicine · doi:10.1177/15598276241280207 · Cited by 11
Opioid Management
Hooten, W. M. (2020) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2020.01.006 · Cited by 11
Rates and types of urine drug screen false negative results compared with confirmatory toxicology testing in major trauma patients
Weiss, S. T., Veach, L. J., McGill, W., & Brent, J. A. (2022) · Clinical Toxicology · doi:10.1080/15563650.2022.2117052 · Cited by 13
Ontological insecurity II: Relationship to attachment, childhood trauma, and subclinical psychotic‐like experiences
Marlowe, N. I., Perry, K. N., & Lee, J. (2019) · Journal of Clinical Psychology · doi:10.1002/jclp.22905 · Cited by 11
Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care
Cruz, A. M. D., Walker, R., Pipes, R., Wakhlu, S., & Trivedi, M. H. (2021) · Addiction Science & Clinical Practice · doi:10.1186/s13722-021-00222-0 · Cited by 11
A Harm Reduction Framework for Integrated Treatment of Co-Occurring Opioid Use Disorder and Trauma-Related Disorders
Israel, B. S., Belcher, A. M., & Ford, J. D. (2024) · Journal of Dual Diagnosis · doi:10.1080/15504263.2023.2295416 · Cited by 11
Combining mHealth Technology and Pharmacotherapy to Improve Mental Health Outcomes and Reduce Human Rights Abuses in West Africa: Intervention Field Trial
Ben‐Zeev, D., Larsen, A., Attah, D. A., Obeng, K. M., Beaulieu, A., Asafo, S. M., Gavi, J. K., Kadakia, A., Sottie, E. Q., Ohene, S., et al. (2024) · JMIR Mental Health · doi:10.2196/53096 · Cited by 10
Psychological flexibility, self-compassion, subjective well-being, and substance misuse in college students: a serial mediation model
Arslan, G., Uzun, K., GÜVEN, A. Z., & Gürsu, O. (2024) · Journal of Ethnicity in Substance Abuse · doi:10.1080/15332640.2024.2366981 · Cited by 16
Optimizing Detection and Prediction of Cognitive Function in Multiple Sclerosis With Ambulatory Cognitive Tests: Protocol for the Longitudinal Observational CogDetect-MS Study
Kratz, A. L., Ehde, D. M., Alschuler, K. N., Pickup, K., Ginell, K. M., & Fritz, N. E. (2024) · JMIR Research Protocols · doi:10.2196/59876 · Cited by 12
The design and rationale of the Biomarkers for Evaluating Spine Treatments trial: a sequential multiple assignment randomized trial
Mauck, M. C., Barth, K. S., Bell, K. M., Brooks, A. K., Chadwick, A. L., Gunn, C. A., Hurley, R. W., Ivanova, A., Piva, S. R., Schneider, M., et al. (2025) · Pain Medicine · doi:10.1093/pm/pnaf032 · Cited by 10
Design, methods, and recruitment outcomes of the Veterans' Pain Care Organizational Improvement Comparative Effectiveness (VOICE) study
Krebs, E. E., Becker, W. C., Nelson, D. B., DeRonne, B., Nugent, S. M., Jensen, A., Amundson, E. C., Manuel, J. K., Borsari, B. E., Kats, A. M., et al. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.107001 · Cited by 12

Authors: McNeely, J., Wu, L.-T., Subramaniam, G., Sharma, G., Cathers, L. A., Svikis, D., Sleiter, L., Russell, L., Nordeck, C., Sharma, A., O'Grady, K. E., Bouk, L. B., Cushing, C., King, J., Wahle, A., & Schwartz, R. P.
Affiliations: National Institutes of Health (US)
From New York University School of Medicine, New York, New York; Duke University Medical Center, Durham, North Carolina; National Institutes of Health, Bethesda, Maryland; The EMMES Corporation, Rockville, Maryland; Virginia Commonwealth University, Richmond, Virginia; Friends Research Institute, Baltimore, Maryland; University of Maryland, College Park, College Park, Maryland; and Duke Translational Research Institute, Kannapolis, North Carolina.
ORCID: McNeely, Jennifer
Wu, Li-Tzy
Subramaniam, Geetha
Sharma, Gaurav
Cathers, Lauretta A.
Svikis, Dace
Nordeck, Courtney
Sharma, Anjalee
Schwartz, Robert P.
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 2016-11-15
Volume: 165
Issue: 10
Pages: 690-699
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/m16-0317
PMC: PMC5291717
OpenAlex: W2517443113
Cited by: 320
References: 68
Citations by year: 2026: 47 · 2025: 51 · 2024: 53 · 2023: 41 · 2022: 34 · 2021: 32 · 2020: 26 · 2019: 19 · 2018: 9 · 2017: 8
FWCI: 11.23
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
Funders: National Institute on Drug Abuse (UG1DA013034, U10DA013727, UG1DA040317, UG1DA013035)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords: substance use screening, primary care, tobacco use, alcohol consumption, prescription drug misuse, cannabis use, sedative use, substance use disorders, screening tool validation, sensitivity and specificity, brief screening
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Marijuana Abuse, Female, Humans, Male, Mass Screening, Middle Aged, Primary Health Care, Surveys and Questionnaires, Sensitivity and Specificity, Tobacco Use Disorder, Substance-Related Disorders, Alcohol-Related Disorders, Prescription Drugs, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks